皮肤科药物杂志 SCISCIE

期刊简介预计审稿时间：一般,3-6周

The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology.

We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality.

Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.

The Journal of Drugs in Dermatology (JDD) 是由著名的医学博士 Perry Robins 创立的 MEDLINE®/PubMed® 索引的同行评审出版物。它成立于 2002 年，是传播皮肤病学信息最快的途径之一，被认为是皮肤病学发展最快的出版物。

我们提供与皮肤科新方法、技术、药物治疗和设备相关的原创文章、获奖病例报告和及时的功能，为读者提供最高质量的同行评审内容。

我们通过平衡的同行评审流程来维持高标准的内容。文章由 160 多位知名专家组成的国际编辑委员会审阅。

《Journal Of Drugs In Dermatology》(皮肤科药物杂志)编辑部通讯方式为JOURNAL OF DRUGS IN DERMATOLOGY, 377 PARK AVE SOUTH, 6TH FLOOR, NEW YORK, USA, NY, 10016。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。